In the present study, we found that CRM1 expression was much higher in CRC tissues than that in pericarcinoma, which was also confirmed in other reports,8, 9 suggesting that CRM1 could serve as a potential therapeutic target for cancer therapy. Here, XPO1 is linked to colorectal carcinoma.